A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)

Clinical trial NCT01953692 · COMPLETED

Trial details

NCT number: NCT01953692
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Multiple Myeloma Hodgkin Lymphoma Non-Hodgkin Lymphoma Diffuse Large B-Cell Lymphoma Follicular Lymphoma Primary Mediastinal B-Cell Lymphoma

Start date: 2013-11-22
Primary completion: 2020-06-26
Enrollment: 197

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.